S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ALLR Allarity Therapeutics Inc

1.1099

0.0949 (9.35%)

27 Dec 2024 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics Inc News

Form 8-K - Current report
Wednesday 20 November 2024 (1 month ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Tuesday 19 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights
Friday 15 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 23 October 2024 (2 months ago) • Edgar (US Regulatory)

Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
Tuesday 22 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 11 October 2024 (3 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
Thursday 10 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 4 October 2024 (3 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program
Thursday 3 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 2 October 2024 (3 months ago) • Edgar (US Regulatory)

More Allarity Therapeutics Inc News Articles

Commonwealth Bank Of Aus...

Australia And New Zealan...

Gold vs US Dollar

Newcrest Mining

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions